Scopus
🔓 Açık Erişim YÖKSİS DOI Eşleşti
SJR Q1
Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with second-generation cryoballoon
Europace · Ocak 2015
YÖKSİS Kayıtları
Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with second generation cryoballoon
Europace · 2015 SCI-Expanded 26 atıf
Doç. Dr. KADRİ MURAT GÜRSES →
Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with second generation cryoballoon
Europace · 2015 SCI-Expanded
Doç. Dr. MUHAMMED ULVİ YALÇIN →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Predictors of left atrial volume index reduction following cryoballoon-based pulmonary vein isolation
2016 ISSN: 1099-5129 SCI-Expanded
Doç. Dr. KADRİ MURAT GÜRSES →
Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with second generation cryoballoon
2015 ISSN: 1099-5129 SCI-Expanded 26 atıf
Doç. Dr. KADRİ MURAT GÜRSES →
M2 muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation
2015 ISSN: 1099-5129 SCI-Expanded 8 atıf
Doç. Dr. KADRİ MURAT GÜRSES →
Predictors of left atrial volume index reduction following cryoballoon based pulmonary vein isolation
2016 ISSN: 1099-5129 SCI-Expanded
Doç. Dr. MUHAMMED ULVİ YALÇIN →
Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with second generation cryoballoon
2015 ISSN: 1099-5129 SCI-Expanded
Doç. Dr. MUHAMMED ULVİ YALÇIN →
M2 muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation
2015 ISSN: 1099-5129 SCI-Expanded
Doç. Dr. MUHAMMED ULVİ YALÇIN →
The association of premature ovarian failure with ventricular repolarization dynamics evaluated by QT dynamicity
2013 ISSN: 1099-5129 SCI-Expanded
Doç. Dr. KADRİ MURAT GÜRSES →
Makale Bilgileri
Dergi
Europace
ISSN10995129
Yayın TarihiOcak 2015
Cilt / Sayfa17 · 379-387
Scopus ID2-s2.0-84924352457
Erişim🔓 Açık Erişim
Özet
Aims The second-generation cryoballoon (Arctic Front Advance™) (Arc-Adv-CB) has a redesigned injection system which distributes the refrigerant homogenously to the frontal balloon surface. The aim of this study was to compare the efficacy and safety of the Arc-Adv-CB and its predecessor (Arctic Front™) (Arc-CB) in patients who underwent pulmonary vein isolation (PVI) for atrial fibrillation (AF). Methods and results Three hundred and six patients (55.35 ± 10.60 years, 47.05% male) were included in the study. A total of 1205 pulmonary veins were attempted for PVI with either Arc-CB or Arc-Adv-CB. The follow-up durations were 30 (23-38) and 10 (8-13) months in Arc-CB and Arc-Adv-CB groups, respectively (P < 0.001). When the blanking period was considered, freedom from AF after a single ablation procedure was 68.53 and 90.83% in patients undergoing PVI with Arc-CB and Arc-Adv-CB, respectively. The most frequent complication was transient phrenic nerve palsy (PNP) which occurred in five(2.54%) and nine(8.26%) of patients undergoing PVI with Arc-CB and Arc-Adv-CB, respectively (P = 0.040). Left atrial (LA) diameter (hazard ratio, HR: 3.552, 95% CI: 2.034-6.201, P < 0.001), smoking history (HR:1.643, 95% CI: 1.011-2.671, P = 0.045), persistent AF (HR:1.725, 95% CI: 1.021-2.915, P = 0.041), duration of AF (HR:1.039, 95% CI: 1.000-1.080, P = 0.047), and early AF recurrence (HR:2.399, 95% CI: 1.443-3.989, P < 0.001) were associated with increased late AF recurrence. On the other hand, intraprocedural vagal reactions (HR: 0.550, 95% CI: 0.331-0.915, P = 0.021) and Arc-Adv-CB use (HR: 0.441, 95% CI: 0.225-0.866, P = 0.017) were associated with lower late AF recurrence. Left atrial diameter (HR: 3.072, 95% CI: 1.646-5.732, P < 0.001), early AF recurrence (HR: 1.906, 95% CI: 1.103-3.291, P = 0.021), and Arc-Adv-CB use (HR: 0.472, 95% CI: 0.239-0.931, P = 0.030) were independent predictors for late AF recurrence. Conclusion Our study has shown that Arc-Adv-CB use is associated with lower late AF recurrences at the cost of an increased risk for PNP.
Yazarlar (11)
1
Kudret Aytemir
2
Kadri Murat Gurses
3
Muhammed Ulvi Yalçın
4
Duygu Kocyigit
5
Muhammet Dural
6
Banu Evranos
7
Hikmet Yorgun
8
Ahmet Hakan Ateş
9
Mehmet Levent Şahiner
10
Ergün Barış Kaya
11
Mehmet Ali Oto
Anahtar Kelimeler
Ablation
Atrial fibrillation
Cryoballoon
Efficacy
Safety
Kurumlar
Hacettepe Üniversitesi
Ankara Turkey
Scimago Dergi (ISSN Eşleşmesi)
Europace
Q1
SJR Skoru3,446
H-Index145
YayıncıOxford University Press
ÜlkeUnited Kingdom
Cardiology and Cardiovascular Medicine (Q1)
Physiology (medical) (Q1)
Metrikler
94
Atıf
11
Yazar
5
Anahtar Kelime